Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant.

Detalles Bibliográficos
Publicado en:	Breast Cancer Research Vol. 25; no. 1; pp. 1 - 11
Autores principales:	Neven, P., Fasching, P. A., Chia, S., Jerusalem, G., De Laurentiis, M., Im, S.-A., Petrakova, K., Bianchi, G. V., Martín, M., Nusch, A., Sonke, G. S., De la Cruz-Merino, L., Beck, J. T., Zarate, J. P., Wang, Y., Chakravartty, A., Wang, C., Slamon, D. J.
Formato:	Journal Article
Publicado:	BioMed Central 8/31/2023
Acceso en línea:	Ver este registro en EBSCOhost

fields	@attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=171309321&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 171309321 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14655411 8UYJ jtl: Breast Cancer Research issn: 14655411 maglogo: N pubinfo: dt: 8/31/2023 vid: 25 iid: 1 pid: 24147 pub: BioMed Central artinfo: ui: 171309321 10.1186/s13058-023-01701-9 171309321 ppf: 1 ppct: 10 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant. aug: au: Neven, P. Fasching, P. A. Chia, S. Jerusalem, G. De Laurentiis, M. Im, S.-A. Petrakova, K. Bianchi, G. V. Martín, M. Nusch, A. Sonke, G. S. De la Cruz-Merino, L. Beck, J. T. Zarate, J. P. Wang, Y. Chakravartty, A. Wang, C. Slamon, D. J. affil: Multidisciplinary Breast Centre, Universitair Ziekenhuis Leuven, Herestraat 49, 3000, Leuven, Belgium sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N